Detection of Clostridium difficile infection

Infection Control and Hospital Epidemiology

Volumn 31, Issue SUPPL. 1, 2010, Pages

  Bartlett, John G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B;

CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTION; CONFERENCE PAPER; DIAGNOSTIC TEST; DISEASE SEVERITY; ENZYME IMMUNOASSAY; HUMAN; INFECTION CONTROL; LABORATORY TEST; NONHUMAN;

CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DIAGNOSTIC TECHNIQUES AND PROCEDURES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS;

EID: 78449259052     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/655999     Document Type: Conference Paper

References (14)

1. O'Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 2009;136(6):1913- 1924.
2. Bryant K, McDonald LC. Clostridium difficile infections in children. Pediatr Infect Dis J 2009;28(2):145-146.
3. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353(23): 2433-2441.
4. Centers for Disease Control and Prevention. Surveillance for communityassociated Clostridium difficile - Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008;57(13):340-343.
5. Rouphael NG, O'Donnell JA, Ghatnagar J, Lewis F, Polgreen PM. Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol 2008;198(6):685.e1-685.e6.
6. Lamontagne F, Labbé AC, Haeck O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg 2007;245(2): 267-272. (Pubitemid 46148486)
7. Crobach MJ, Dekkers OM, Wilcox MH, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009;15(12):1053-1066.
8. Quinn CD, Sefers SE, Babiker W, et al. C. Diff Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens. J Clin Microbiol 2010;48(2): 603-605.
9. Peterson LR, Robicsek A. Does my patient have Clostridium difficile infection? Ann Intern Med 2009;151(3):176-179.
10. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320(4): 204-210. (Pubitemid 19034145)
11. Mohan SS, McDermott BP, Parchuri S, Cunha BA. Lack of value of repeat stool testing for Clostridium difficile toxin. Am J Med 2006;119(4): 356.e7-356.e8.
12. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(5):431-455.
13. Bouadma L, Lyut CE, Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomized controlled trial. Lancet 2010;375(9713):463-474.
14. Lowy I, Molrine DC, Leav BA, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 2010;362(3): 197-205.